Brief: DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization As A Meaningful Step To Enhance Value For Shareholders
April 21 (Reuters) - Pacira Biosciences Inc PCRX.O: DOMA PERPETUAL SUPPORTS PACIRA'S NEW $300 MILLION SHARE REPURCHASE AUTHORIZATION AS A MEANINGFUL STEP TO ENHANCE VALUE FOR SHAREHOLDERS DOMA PERPETUAL - BELIEVES PACIRA'S STOCK IS UNDERVALUED DOMA PERPETUAL - OWNS 4.2% OF PACIRA BIOSCIENCES Source text: ID:nPn748T7Ya Further company coverage: PCRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal